2XM-29854-94307
3 vaccinations
21 coded responses
38 check-ins
21 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 198 / DE
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2020-12-29
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Dizziness, Vertigo — Feeling: Fair · NauseaFree text: Dizziness/vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
-
2021-01-18
Survey response — day 21, dose 1MedDRA: Headache, Self-medication, Vertigo — Feeling: Good · Be unable to workFree text: Have had intermittent headaches; vertigo from post VAX day 8 and 9 resolved with meclizineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
-
2021-01-19
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · NauseaFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Vertigo — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Dizziness/vertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Dizziness intermittentlyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Vertigo — Feeling: GoodFree text: Vertigo/dizziness-sporadicMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — day 7, dose 2MedDRA: Dizziness, Vertigo — Feeling: Fair · Be unable to workFree text: Vertigo/dizziness: constant. I had this same feeling d7-8 after my first doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-23
Survey response — day 35, dose 2MedDRA: Abnormal uterine bleeding, Pelvic pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Abnormal uterine bleeding Pelvic painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — day 42, dose 2MedDRA: Abdominal pain lower, Menstrual disorder — Feeling: FairFree text: New abnormal menstrual cycles and pelvic cramps since dose 2, not previously reported bc I thought it wasnt relevant. Now Im hearing this is a more common issue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — 3 months, dose 2MedDRA: Colitis ulcerative, Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Flare of ulcerative colitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-07
- 2021-07-20
-
2021-11-02
Dose 3 — Moderna
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: Flare of IBDMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Survey response — days 1–6 daily, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Site: PainFree text: IBD flareMedDRA releases: 2024-11 · check-in free text available
-
2021-11-06
Survey response — days 1–6 daily, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: IBD flareMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Irritable bowel syndrome, Pre-existing disease — Feeling: GoodFree text: IBD flareMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — day 7, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: IBD flareMedDRA releases: 2024-11 · check-in free text available
-
2021-11-23
Survey response — day 21, dose 3MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
-
2021-11-30
Survey response — day 28, dose 3MedDRA: Irritable bowel syndrome, Pre-existing disease — Feeling: GoodFree text: IBD flareongoingMedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
- 2021-12-14
- 2022-02-01
- 2022-05-08
-
2022-11-02
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID 19 infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-02
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-03
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Moderna | No |
Call center
4 call center cases
2 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Dizziness/vertigo
Release 2 — day 21, dose 1
Symptoms: Have had intermittent headaches; vertigo from post VAX day 8 and 9 resolved with meclizine
Release 2 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness/vertigo
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness intermittently
Systemic reaction (other): Vertigo/dizziness-sporadic
Release 2 — day 7, dose 2
Systemic reaction (other): Vertigo/dizziness: constant. I had this same feeling d7-8 after my first dose
Release 4 — day 35, dose 2
Symptoms: Abnormal uterine bleeding Pelvic pain
Release 4 — day 42, dose 2
Symptoms: New abnormal menstrual cycles and pelvic cramps since dose 2, not previously reported bc I thought it wasnt relevant. Now Im hearing this is a more common issue.
Release 7 — 3 months, dose 2
Symptoms: Flare of ulcerative colitis
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Flare of IBD
Systemic reaction (other): IBD flare
Systemic reaction (other): IBD flare
Systemic reaction (other): IBD flare
Release 10 — day 7, dose 3
Systemic reaction (other): IBD flare
Release 10 — day 21, dose 3
Symptoms: Sore throat
Release 10 — day 28, dose 3
Symptoms: IBD flareongoing
Release 12 — 12 months, dose 3
Symptoms: COVID 19 infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain lower | ✓ | ✓ | ✓ |
| SD | Abnormal uterine bleeding | ✓ | ✓ | ✓ |
| SD | Colitis ulcerative | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Irritable bowel syndrome | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pelvic pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Irritable bowel syndrome | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release